Medical Cannabis

Generic Name
Medical Cannabis
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
FTS5RM302N
Background

The use of the plant species Cannabis sativa and Cannabis indica, popularly known as marijuana, has gained popularity in recent years for the management of a wide variety of medical conditions as a wave of legalization in North America has changed public and medical opinion on its use. Consequently, an expanding body of evidence has begun to emerge that has ...

Associated Conditions
-
Associated Therapies
-

Laboratory Smoking of Marijuana "Blunts"

Phase 1
Completed
Conditions
Interventions
First Posted Date
2018-06-06
Last Posted Date
2019-10-02
Lead Sponsor
Battelle Memorial Institute
Target Recruit Count
8
Registration Number
NCT03546790
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Battelle Memorial Institute, Baltimore, Maryland, United States

The Effect of Cannabis on Dementia Related Agitation and Aggression

First Posted Date
2017-11-01
Last Posted Date
2022-03-08
Lead Sponsor
TO Pharmaceuticals
Target Recruit Count
64
Registration Number
NCT03328676
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Laniado Hospital, Netanya, Israel

Effects of Marijuana on Symptoms of OCD

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-09-07
Last Posted Date
2020-11-18
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
14
Registration Number
NCT03274440
Locations
๐Ÿ‡บ๐Ÿ‡ธ

New York State Psychiatric Institute, New York, New York, United States

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-08-18
Last Posted Date
2022-07-26
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
15
Registration Number
NCT03253926
Locations
๐Ÿ‡บ๐Ÿ‡ธ

New York State Psychiatric Institute, New York, New York, United States

Nabilone in Cannabis Users With PTSD

First Posted Date
2017-08-16
Last Posted Date
2022-07-15
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
4
Registration Number
NCT03251326
Locations
๐Ÿ‡บ๐Ÿ‡ธ

New York State Psychiatric Institute, New York, New York, United States

Safety and Efficacy of Cannabis in Tourette Syndrome

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2017-08-11
Last Posted Date
2021-01-25
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
15
Registration Number
NCT03247244
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Toronto Western Hospital - Tourette Syndrome Neurodevelopmental Clinic, Toronto, Ontario, Canada

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

First Posted Date
2017-08-11
Last Posted Date
2019-08-13
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
1
Registration Number
NCT03246113
Locations
๐Ÿ‡บ๐Ÿ‡ธ

New York State Psychiatric Institute, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Columbia University Medical Center- Department of Radiation Oncology, New York, New York, United States

Brain Imaging of Cannabinoid Receptors

First Posted Date
2017-07-02
Last Posted Date
2023-03-21
Lead Sponsor
Johns Hopkins University
Target Recruit Count
28
Registration Number
NCT03204305
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Differences in Cannabis Impairment and Its Measurement Due to Route of Administration

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-04-21
Last Posted Date
2023-02-21
Lead Sponsor
Johns Hopkins University
Target Recruit Count
23
Registration Number
NCT03122691
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain

Phase 2
Completed
Conditions
Interventions
First Posted Date
2017-04-04
Last Posted Date
2024-06-18
Lead Sponsor
University of California, San Diego
Target Recruit Count
5
Registration Number
NCT03099005
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UC Center for Medicinal Cannabis Research, UC San Diego, San Diego, California, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath